- Home
- NBY vs HSCS Comparison
NBY vs HSCS Comparison
Compare NBY & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- HSCS
- Stock Information
- Founded
- NBY 2000
- HSCS 2007
- Country
- NBY United States
- HSCS United States
- Employees
- NBY N/A
- HSCS N/A
- Industry
- NBY
- HSCS Medical Specialities
- Sector
- NBY
- HSCS Health Care
- Exchange
- NBY Nasdaq
- HSCS Nasdaq
- Market Cap
- NBY 3.4M
- HSCS 3.7M
- IPO Year
- NBY 2007
- HSCS 2022
- Fundamental
- Price
- NBY $0.58
- HSCS $3.58
- Analyst Decision
- NBY Strong Buy
- HSCS Strong Buy
- Analyst Count
- NBY 1
- HSCS 2
- Target Price
- NBY $0.85
- HSCS $13.00
- AVG Volume (30 Days)
- NBY 41.7K
- HSCS 47.2K
- Earning Date
- NBY 05-15-2025
- HSCS 07-28-2025
- Dividend Yield
- NBY N/A
- HSCS N/A
- EPS Growth
- NBY N/A
- HSCS N/A
- EPS
- NBY 0.57
- HSCS N/A
- Revenue
- NBY $9,781,000.00
- HSCS N/A
- Revenue This Year
- NBY $23.91
- HSCS N/A
- Revenue Next Year
- NBY $32.05
- HSCS N/A
- P/E Ratio
- NBY $1.27
- HSCS N/A
- Revenue Growth
- NBY 20.52
- HSCS 261.17
- 52 Week Low
- NBY $0.36
- HSCS $2.36
- 52 Week High
- NBY $3.15
- HSCS $5.90
- Technical
- Relative Strength Index (RSI)
- NBY 52.01
- HSCS 49.06
- Support Level
- NBY $0.55
- HSCS $3.48
- Resistance Level
- NBY $0.61
- HSCS $4.29
- Average True Range (ATR)
- NBY 0.02
- HSCS 0.47
- MACD
- NBY 0.00
- HSCS -0.04
- Stochastic Oscillator
- NBY 50.00
- HSCS 22.58
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.